← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
MF Analyser

Capitalmind Flexi Cap Fund

Regular Plan · Growth · Flexi Cap · Scheme code 153739

NAV₹10.2660as on 25 Sep 2026
Fund houseCapitalmind Mutual Fund
CategoryFlexi Cap
Plan & optionRegular · Growth
History1.1 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme -2.122.402.14 0.23—— ——0.88
Nifty 500
benchmark		 0.874.312.15 5.2012.4911.41 ——15.49
Flexi Cap
category median		 ——— -0.1110.749.09 —12.22—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 11.4% -0.49 -0.64 0.64 1.37% -9.3% 79.57
Nifty 500
benchmark		 17.2%0.35 0.47—— -37.3%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 12 months this scheme and its benchmark share.

Growth of ₹100 since launch

94981021072026MF Analyser

Drawdown from peak (%)

0%-3%-7%-10%2026

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
80% 64% 0.89 8.4% 0.20 1.23

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 12 months this scheme and Nifty 500 share.

MF Analyser

Capitalmind Flexi Cap Fund

Regular Plan · Growth

Allocation

By asset

Equity98.86%
Cash & Equivalents0.86%
Debt0.28%

By market cap

Concentration

Number of stocks34
Top 5 stocks20.75%
Top 10 stocks37.93%
Top 20 stocks68.53%
Lines in the filing36
Largest holding5.38%
Largest sectorPharmaceuticals & Biotechnology 21.81%
Effective stocks31.4
Sectors held19
Cash0.86%

Effective stocks is what the concentration works out to: a fund holding 34 names but most of its money in a few behaves like a fund of 31. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology — 21.8%Industrial Products — 17.9%Banks — 14.5%Auto Components — 5.9%Capital Markets — 5.0%Non - Ferrous Metals — 3.4%Consumer Durables — 3.3%Beverages — 3.2%IT - Software — 3.1%Other — 21.9%Pharmaceuticals & Biotech…21.8%Industrial Products17.9%Banks14.5%Auto Components5.9%Capital Markets5.0%Non - Ferrous Metals3.4%Consumer Durables3.3%Beverages3.2%IT - Software3.1%Other21.9%
Pharmaceuticals & Biotechnology21.81%
Industrial Products17.85%
Banks14.49%
Auto Components5.94%
Capital Markets5.02%
Non - Ferrous Metals3.42%
Consumer Durables3.26%
Beverages3.19%
IT - Software3.12%
Retailing3.06%
Automobiles2.93%
Food Products2.69%
Cement & Cement Products2.67%
Healthcare Services2.67%
Chemicals & Petrochemicals2.61%
Agricultural Food & other Products2.54%
Electrical Equipment1.59%
Cash & Equivalents0.86%
CRISIL AAA0.21%
Sovereign0.07%
MF Analyser

Capitalmind Flexi Cap Fund

Regular Plan · Growth · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr		% of fund
1 Welspun Corp Limited Industrial Products 107,153 26 5.38%
2 R R Kabel Limited Industrial Products 64,856 19 3.99%
3 The Federal Bank Limited Banks 531,620 19 3.98%
4 Bank of Maharashtra Banks 2,205,261 18 3.80%
5 Laurus Labs Limited Pharmaceuticals & Biotechnology 89,488 17 3.60%
6 Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology 33,420 17 3.55%
7 Cummins India Limited Industrial Products 32,634 17 3.50%
8 Karur Vysya Bank Limited Banks 473,115 16 3.45%
9 Hindalco Industries Limited Non - Ferrous Metals 160,602 16 3.42%
10 Titan Company Limited Consumer Durables 30,470 16 3.26%
11 The Karnataka Bank Limited Banks 463,611 16 3.26%
12 Radico Khaitan Limited Beverages 33,897 15 3.19%
13 Divi's Laboratories Limited Pharmaceuticals & Biotechnology 15,850 15 3.15%
14 Oracle Financial Services Software Limited IT - Software 11,848 15 3.12%
15 FSN E-Commerce Ventures Limited Retailing 417,177 15 3.06%
16 Bharat Forge Limited Auto Components 68,976 15 3.05%
17 Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology 71,272 14 2.97%
18 Aurobindo Pharma Limited Pharmaceuticals & Biotechnology 81,461 14 2.94%
19 Granules India Limited Pharmaceuticals & Biotechnology 168,367 14 2.93%
20 Bajaj Auto Limited Automobiles 11,486 14 2.93%
21 Sona BLW Precision Forgings Limited Auto Components 169,580 14 2.89%
22 Nestle India Limited Food Products 85,513 13 2.69%
23 Anand Rathi Wealth Limited Capital Markets 58,039 13 2.69%
24 Grasim Industries Limited Cement & Cement Products 37,792 13 2.67%
25 Zydus Lifesciences Limited Pharmaceuticals & Biotechnology 109,638 13 2.67%
26 Apollo Hospitals Enterprise Limited Healthcare Services 14,265 13 2.67%
27 Polycab India Limited Industrial Products 13,376 13 2.65%
28 Himadri Speciality Chemical Limited Chemicals & Petrochemicals 188,751 12 2.61%
29 Marico Limited Agricultural Food & other Products 147,809 12 2.54%
30 Kirloskar Oil Engines Limited Industrial Products 52,790 11 2.33%
MF Analyser

Capitalmind Flexi Cap Fund

Regular Plan · Growth · where the money sits

What the manager did last month

Between the filings of 31 Jul 2026 and 31 Aug 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹0 cr ₹0 cr 5 5 +5.65%
StockShares tradedShares PriceValue
₹ cr
New position
The Karnataka Bank Limited 463,611 entered — 15.5
Divi's Laboratories Limited 15,850 entered — 15.0
Bajaj Auto Limited 11,486 entered — 13.9
Sona BLW Precision Forgings Limited 169,580 entered — 13.8
Grasim Industries Limited 37,792 entered — 12.7
Sold out of
Navin Fluorine International Limited 17,904 exited — 13.6
Capri Global Capital Limited 547,350 exited — 12.7
The Jammu & Kashmir Bank Limited 796,362 exited — 12.4
Lupin Limited 50,696 exited — 12.2
The Phoenix Mills Limited 64,384 exited — 12.2
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr
Debt: bills, CDs and commercial paper ₹0 cr ₹1 cr +₹1 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 27 Sep 2026.